La Biblioteca le brinda un dossier informativo actualizado sobre Coronavirus (COVID-19)

Ministerio de Salud: Recomendaciones

 

Organización Panamericana de la Salud (OPS) – Argentina / CDC

OPS: cursos sobre COVID-19 en español

OPS Recursos de información relacionados con el nuevo coronavirus

Vitrina del conocimiento: Nuevo coronavirus

CDC –  Centros para el Control y la Prevención de Enfermedades – USA Recomendaciones, cómo protegerse

 

Sociedades científicas: Recursos

Actualización de los Lineamientos Técnicos Campaña Nacional de Vacunación contra la COVID-19

https://bancos.salud.gob.ar/sites/default/files/2021-03/actualizacion-lineamientos-tecnicos-vacunacion-covid19.pdf

Noveno Informe de Seguridad en Vacunas

https://bancos.salud.gob.ar/sites/default/files/2021-03/noveno-informe-de-seguridad-en-vacunas.pdf

Actualización de los Lineamientos Técnicos Campaña Nacional de Vacunación contra la COVID-19

https://bancos.salud.gob.ar/sites/default/files/2021-03/actualizacion-lineamientos-tecnicos-vacunacion-covid19.pdf

Noveno Informe de Seguridad en Vacunas

https://bancos.salud.gob.ar/sites/default/files/2021-03/noveno-informe-de-seguridad-en-vacunas.pdf

RACIM de ivermectina (actualización de la versión 3)

https://www.fundacionfemeba.org.ar/blog/farmacologia-7/post/racim-ivermectina-en-covid19-actualizacion-48807

Novel Coronavirus 2019, Actualización 04-04-2021 – Representación OPS/OMS Argentina https://www.paho.org/es/file/85134/download?token=5JwT00jK

IDSA Guidelines on the Treatment and Management of Patients with COVID-19

https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v4.1.1.pdf

Vacuna contra COVID-19 y administración de otras vacunas

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/03/Vac-COVID-y-otras-vacunas-Informe-CIME-v.final_.pdf

Actualización del manual del vacunador de Sputnik V

https://bancos.salud.gob.ar/sites/default/files/2021-02/actualizacion-manual-vacunador-sputnik-v-10-02-21.pdf

Manual vacunador Sinopharm

https://bancos.salud.gob.ar/sites/default/files/2021-03/manual-vacunador-sinopharm_12-3-2021.pdf

INFORMACIÓN REGIONAL Y GLOBAL CONSOLIDADA SOBRE EVENTOS SUPUESTAMENTE ATRIBUIBLES A LA VACUNACIÓN O INMUNIZACIÓN (ESAVI) CONTRA LA COVID-19 Y OTRAS ACTUALIZACIONES

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/03/Actualizacion-periodica-ESAVI-Seguridad-Vacunas-COVID-19-11-MAR.pdf

OPS. Actualización Epidemiológica: Enfermedad por coronavirus (COVID-19) – 9 de febrero de 2021

https://www.paho.org/es/documentos/actualizacion-epidemiologica-enfermedad-por-coronavirus-covid-19-9-febrero-2021

VACUNAS CONTRA LA COVID-19. Coadministración con otras vacunas

http://www.colfarma.info/colfarma/wp-content/uploads/2021/03/Boletin-ESPECIAL-01-03-2021-IMPORTANTE-VACUNAS-CONTRA-LA-COVID-19-Coadministracion-con-otras-vacunas.htm

ALERTA DE LA RPVF 22/02/2021 Sinopharm

http://www.colfarma.info/colfarma/alerta-de-la-rpvf-22-02-2021-sinopharm/

ALERTA DE LA RPVF 18/02/2021 Vacuna Sputnik V: Nueva presentación del Componente 1

http://www.colfarma.info/colfarma/alerta-de-la-rpvf-18-02-2021-vacuna-sputnik-v-nueva-presentacion-del-componente-1/

ALERTA DE LA RPVF 11/02/2021 SPUTNIK V: ACTUALIZACIÓN SOBRE SITUACIONES ESPECIALES EN LA POBLACIÓN OBJETIVO A VACUNAR

http://www.colfarma.info/colfarma/alerta-de-la-rpvf-11-02-2021-sputnik-v-actualizacion-sobre-situaciones-especiales-en-la-poblacion-objetivo-a-vacunar/

Comunicación sobre datos preliminares de seguridad de vacunas que se están administrando en países de la Región. (20/01/21)

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/01/ESP-Nota-seguridad-de-vacunas-I.pdf

Resumen inicial de ESAVIs reportados para vacunas que se están utilizando en países de la Región.(19/01/21)

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/01/ESP-tablas-sobre-seguridad-de-vacunas.pdf

Sputnik V: actualización de las condiciones para la conservación y uso de la vacuna

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/02/Memo-SPUNTIK-V-3.2.2021.pdf

Evaluación del riesgo por contagio de coronavirus SARS-CoV-2 y medidas preventivas recomendadas en la prestación de servicios profesionales farmacéuticos asistenciales (SPFA)

https://www.sefac.org/system/files/2020-06/Documento%20SEFAC%20evaluaci%C3%B3n%20de%20riesgos%20en%20SPFA%20y%20coronavirus_0.pdf

Seguridad y eficacia preliminar de las vacunas para la prevención de COVID-19

http://www.evidencia.org/index.php/Evidencia/article/view/6912/4503

Autorización con carácter de emergencia: vacuna COVISHIELD/ ChAdOx1nCoV-19 Corona Virus Vaccine – Recombinant

https://www.boletinoficial.gob.ar/detalleAviso/primera/240575/20210209

VACUNAS CONTRA COVID-19

https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-818-VA-Vacuna-covid-1.pdf

COVID-19: INFORMACIÓN SOBRE PLATAFORMAS DE VACUNAS

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/01/Informe-RACIM-COVID19-Plataformas-de-vacunas.pdf

Vacuna contra coronavirus: No está comprobado que todos Los pacientes que hayan tenido una reacción alérgica grave deban evitar la vacunación

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/Gacetilla-Vacuna-Covid19-AAAeIC-AAAIC.pdf

Mitos y verdades sobre la vacunación COVID-19 en Argentina

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/Mitos-y-Verdades-COVID-19-vacunas-Min-Salud-nov-2020.pdf

Ventilación y COVID-19 en la Industria

https://www.argentina.gob.ar/sites/default/files/ficha_tecnica_ventilacion_y_covid_150920.pdf

COVID-19: Acciones regulatorias de ANMAT

https://www.argentina.gob.ar/anmat/covid-19-acciones-regulatorias-de-anmat

PROTOCOLO DE ACTUACIÓN DESDE LAS FARMACIAS COMUNITARIAS

https://www.colfacor.org.ar/administrador_web/kcfinder/upload/files/info_coronavirus_farmacias%284%29.pdf

Impacto de los sistemas de ventilación en la transmisión del SARSCoV2Recomendaciones generales para los edificios de uso público

https://www.comunidad.madrid/sites/default/files/doc/sanidad/samb/doc_tec_ventilacion_el_sars-cov-2.pdf

Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Global research on coronavirus disease (COVID-19)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov

COVID-19INTERACCIONES MEDICAMENTOSAS
https://www.argentina.gob.ar/sites/default/files/covid-19_interacciones-medicamentosas.pdf

COVID-19 resúmenes de artículos en español. Sociedad Iberoamericana de Información Científica
https://www.siicsalud.com/

Repositorio COVID-19 (ITAES)
https://www.itaes.org.ar/RepositorioCOVID19.aspx?secId=81

 

Artículos científicos

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

https://www.nejm.org/doi/pdf/10.1056/NEJMc2101667?articleTools=true

Changes to the sebum lipidome upon COVID-19 infection observed via rapid sampling from the skin

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00066-3/fulltext

Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro

https://www.mdpi.com/2076-0817/10/3/272/pdf

Medication use during COVID-19: Review of recent evidence

https://www.cfp.ca/content/cfp/67/3/171.full.pdf

Safety of new mRNA Vaccines Against Covid in Severe Allergic Patients

http://www.jiaci.org/revistas/doi10.18176_jiaci.0683.pdf

COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases

https://www.rheumatology.org/Portals/0/Files/COVID-19-Vaccine-Clinical-Guidance-Rheumatic-Diseases-Summary.pdf

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2

https://www.nejm.org/doi/full/10.1056/NEJMc2102131?query=WB

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

https://www.nature.com/articles/s41586-021-03431-4_reference.pdf

IDSA Guidelines on the Treatment and Management of Patients with COVID-19

https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v4.1.1.pdf

Vacuna contra COVID-19 y administración de otras vacunas

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/03/Vac-COVID-y-otras-vacunas-Informe-CIME-v.final_.pdf

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

https://jamanetwork.com/journals/jama/fullarticle/2776039

Facing up to the COVID-19 pandemic in Argentina

https://www.nature.com/articles/s41590-021-00873-w.pdf

Potential Role of Vitamin B6 in Ameliorating the Severity of COVID-19 and Its Complications

https://www.frontiersin.org/articles/10.3389/fnut.2020.562051/full

OBESITY MAY HAMPER SARS-CoV-2 VACCINE IMMUNOGENICITY

https://www.medrxiv.org/content/10.1101/2021.02.24.21251664v1.full.pdf

Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients

https://www.sciencedirect.com/science/article/pii/S2452302X20305489

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

https://jamanetwork.com/journals/jama/fullarticle/2776039

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMoa2031994?query=WB

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19. A Randomized Clinical Trial

https://jamanetwork.com/journals/jama/fullarticle/2777389?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jama.2021.3071

Sofosbuvir as a potential option for the treatment of COVID-19

https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9609/8800

Treatments for COVID-19: emerging drugs against the coronavirus

https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9639/8783

Colchicine reduces the risk of COVID-19-related complications

https://www.icm-mhi.org/en/pressroom/news/colchicine-reduces-risk-covid-19-related-complications

Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

https://www.clinicalimaging.org/article/S0899-7071(21)00020-6/fulltext#%20

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

https://bit.ly/3txtx75

Decontaminating N95 respirators during the COVID-19 pandemic: simple and practical approaches to increase decontamination capacity, speed, safety and ease of use

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30570-3/pdf

Decontamination of common healthcare facility surfaces contaminated with SARS-CoV-2 using peracetic acid dry fogging

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30581-8/pdf

FLCC. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

https://osf.io/wx3zn/?fbclid=IwAR0r7JRRaG4yQ08EiOrJFw2GA0Lkc2sL3eSTj9Bjkp_-BZYNi5saLVk8EAo

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30464-8/fulltext

Drug interactions for elderly with respiratory disorders and times of COVID-19: a systematic scoping review

https://revistas.udea.edu.co/index.php/vitae/article/view/343796/20804337

Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”

https://www.repositoriosalud.es/bitstream/10668/3215/1/Entrenas_EffectOfCalcifediol.pdf

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

https://bit.ly/3avhKxD

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection

https://link.springer.com/article/10.1007/s00431-021-03940-4

From Hydroxychloroquine to Ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?

https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab005/6106246

Focus on COVID-19: Antiviral polymers in drugs and vaccines

https://www.polimery.umed.wroc.pl/pdf/2020/50/2/75.pdf

Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro

https://www.mdpi.com/1999-4915/13/1/121/pdf

Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection

https://www.researchsquare.com/article/rs-148845/v1

Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines

http://www.jiaci.org/revistas/doi10.18176_jiaci.0667.pdf

Allergic reactions to COVID-19 -vaccinations – unveiling the secret(s)

https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.14734

La Quercetina como un potencial nutracéutico contra la enfermedad por coronavirus 2019 (COVID-19)

https://revistaseug.ugr.es/index.php/ars/article/view/15684/15561

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

https://science.sciencemag.org/content/early/2021/01/22/science.abf4058/tab-pdf

Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective

https://www.sciencedirect.com/science/article/pii/S187140212030535X?via%3Dihub

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

https://bit.ly/3quNVV9

mRNA-1273 Study Group. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

https://bit.ly/39U0iE9

Manifestações Cutâneas Associadas à COVID-19: Uma Revisão Narrativa

https://actamedicaportuguesa.com/revista/index.php/amp/article/view/14574/6218

Clinical and Pathogenic Correlations Between SARS-CoV-2 Infection and Hemolytic Uremic Syndrome in Children

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726516/pdf/maedica-15-376.pdf

Administration of intravenous immunoglobulin in the treatment of COVID‐19: a review of available evidence

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26727

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection

https://www.sciencedirect.com/science/article/pii/S0169409X20302775?via%3Dihub

Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro

https://www.sciencedirect.com/science/article/pii/S0024320520316428?via%3Dihub

Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System

https://www.ackdjournal.org/article/S1548-5595(20)30112-9/fulltext

A systematic review of possible airborne transmission of the COVID-19 virus (SARS-CoV-2) in the indoor air environment

https://www.sciencedirect.com/science/article/pii/S0013935120315097?via%3Dihub

Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?

https://www.maturitas.org/article/S0378-5122(20)30346-7/fulltext

Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19

https://www.mdpi.com/2072-6643/12/12/3760/pdf

Vaccinating Pregnant and Lactating Patients Against COVID-19

https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19